Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2

Li Wang, Yujuan Zhang, Kangdong Liu, Hanyong Chen, Ran Yang, Xiaoli Ma, Hong Gyum Kim, Ann M. Bode, Dong Joon Kim, Zigang Dong

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Carnosol is a phenolic diterpene that is isolated from rosemary, sage, and oregano. It has been reported to possess anti-oxidant, anti-inflammatory, and anti-cancer properties. However, the molecular mechanism of carnosol's activity against gastric cancer has not been investigated. Herein, we report that carnosol is an RSK2 inhibitor that attenuates gastric cancer growth. Carnosol reduced anchorage-dependent and-independent gastric cancer growth by inhibiting the RSKs-CREB signaling pathway. The results of in vitro screening and cell-based assays indicated that carnosol represses RSK2 activity and its downstream signaling. Carnosol increased the G2/M phase and decreased S phase cell cycle and also induced apoptosis through the activation of caspases 9 and 7 and inhibition of Bcl-xL expression. Notably, oral administration of carnosol suppressed patient-derived gastric tumor growth in an in vivo mouse model. Our findings suggest that carnosol is an RSK2 inhibitor that could be useful for treating gastric cancer.

Original languageEnglish (US)
Pages (from-to)34200-34212
Number of pages13
JournalOncotarget
Volume9
Issue number76
StatePublished - Sep 1 2018

Fingerprint

Stomach
Growth
Stomach Neoplasms
Neoplasms
Origanum
Caspase 7
carnosol
Caspase 9
Diterpenes
G2 Phase
S Phase
Oxidants
Cell Division
Oral Administration
Cell Cycle
Anti-Inflammatory Agents
Apoptosis

Keywords

  • Carnosol
  • Gastric cancer
  • Patient-derived tumor xenograft
  • RSK2

Cite this

Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2. / Wang, Li; Zhang, Yujuan; Liu, Kangdong; Chen, Hanyong; Yang, Ran; Ma, Xiaoli; Kim, Hong Gyum; Bode, Ann M.; Kim, Dong Joon; Dong, Zigang.

In: Oncotarget, Vol. 9, No. 76, 01.09.2018, p. 34200-34212.

Research output: Contribution to journalArticle

Wang, L, Zhang, Y, Liu, K, Chen, H, Yang, R, Ma, X, Kim, HG, Bode, AM, Kim, DJ & Dong, Z 2018, 'Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2', Oncotarget, vol. 9, no. 76, pp. 34200-34212.
Wang L, Zhang Y, Liu K, Chen H, Yang R, Ma X et al. Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2. Oncotarget. 2018 Sep 1;9(76):34200-34212.
Wang, Li ; Zhang, Yujuan ; Liu, Kangdong ; Chen, Hanyong ; Yang, Ran ; Ma, Xiaoli ; Kim, Hong Gyum ; Bode, Ann M. ; Kim, Dong Joon ; Dong, Zigang. / Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2. In: Oncotarget. 2018 ; Vol. 9, No. 76. pp. 34200-34212.
@article{2fb3ed71ea174a1bb2c5a915a10dbfad,
title = "Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2",
abstract = "Carnosol is a phenolic diterpene that is isolated from rosemary, sage, and oregano. It has been reported to possess anti-oxidant, anti-inflammatory, and anti-cancer properties. However, the molecular mechanism of carnosol's activity against gastric cancer has not been investigated. Herein, we report that carnosol is an RSK2 inhibitor that attenuates gastric cancer growth. Carnosol reduced anchorage-dependent and-independent gastric cancer growth by inhibiting the RSKs-CREB signaling pathway. The results of in vitro screening and cell-based assays indicated that carnosol represses RSK2 activity and its downstream signaling. Carnosol increased the G2/M phase and decreased S phase cell cycle and also induced apoptosis through the activation of caspases 9 and 7 and inhibition of Bcl-xL expression. Notably, oral administration of carnosol suppressed patient-derived gastric tumor growth in an in vivo mouse model. Our findings suggest that carnosol is an RSK2 inhibitor that could be useful for treating gastric cancer.",
keywords = "Carnosol, Gastric cancer, Patient-derived tumor xenograft, RSK2",
author = "Li Wang and Yujuan Zhang and Kangdong Liu and Hanyong Chen and Ran Yang and Xiaoli Ma and Kim, {Hong Gyum} and Bode, {Ann M.} and Kim, {Dong Joon} and Zigang Dong",
year = "2018",
month = "9",
day = "1",
language = "English (US)",
volume = "9",
pages = "34200--34212",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "76",

}

TY - JOUR

T1 - Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2

AU - Wang, Li

AU - Zhang, Yujuan

AU - Liu, Kangdong

AU - Chen, Hanyong

AU - Yang, Ran

AU - Ma, Xiaoli

AU - Kim, Hong Gyum

AU - Bode, Ann M.

AU - Kim, Dong Joon

AU - Dong, Zigang

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Carnosol is a phenolic diterpene that is isolated from rosemary, sage, and oregano. It has been reported to possess anti-oxidant, anti-inflammatory, and anti-cancer properties. However, the molecular mechanism of carnosol's activity against gastric cancer has not been investigated. Herein, we report that carnosol is an RSK2 inhibitor that attenuates gastric cancer growth. Carnosol reduced anchorage-dependent and-independent gastric cancer growth by inhibiting the RSKs-CREB signaling pathway. The results of in vitro screening and cell-based assays indicated that carnosol represses RSK2 activity and its downstream signaling. Carnosol increased the G2/M phase and decreased S phase cell cycle and also induced apoptosis through the activation of caspases 9 and 7 and inhibition of Bcl-xL expression. Notably, oral administration of carnosol suppressed patient-derived gastric tumor growth in an in vivo mouse model. Our findings suggest that carnosol is an RSK2 inhibitor that could be useful for treating gastric cancer.

AB - Carnosol is a phenolic diterpene that is isolated from rosemary, sage, and oregano. It has been reported to possess anti-oxidant, anti-inflammatory, and anti-cancer properties. However, the molecular mechanism of carnosol's activity against gastric cancer has not been investigated. Herein, we report that carnosol is an RSK2 inhibitor that attenuates gastric cancer growth. Carnosol reduced anchorage-dependent and-independent gastric cancer growth by inhibiting the RSKs-CREB signaling pathway. The results of in vitro screening and cell-based assays indicated that carnosol represses RSK2 activity and its downstream signaling. Carnosol increased the G2/M phase and decreased S phase cell cycle and also induced apoptosis through the activation of caspases 9 and 7 and inhibition of Bcl-xL expression. Notably, oral administration of carnosol suppressed patient-derived gastric tumor growth in an in vivo mouse model. Our findings suggest that carnosol is an RSK2 inhibitor that could be useful for treating gastric cancer.

KW - Carnosol

KW - Gastric cancer

KW - Patient-derived tumor xenograft

KW - RSK2

UR - http://www.scopus.com/inward/record.url?scp=85054130665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054130665&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 34200

EP - 34212

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 76

ER -